for future analysis. The majority of short-term readmissions are related to the index procedure; however, long-term readmission rates are related to systemic comorbidities. Targeted patient interventions may improve readmission rates, particularly in those with nonprivate insurance.
Objectives: Groin wounds remain a significant contributor to patient morbidity and rising health care costs. Negative-pressure therapy has been shown to decrease infection rates in sternal and groin incisions by retrospective analyses. This study prospectively evaluated negativepressure therapy as a means to decrease wound complications and associated health care costs.
Methods: This was a randomized, prospective, single-institution study of 140 femoral incisions closed primarily following elective vascular surgery. Incisions were categorized as either low-risk or high-risk for wound complications on the basis of body mass index >30 kg/m 2 , pannus, reoperative surgery, prosthetic graft, poor nutrition, immunosuppression, or HbA 1c >8. Low-risk incisions (n ¼ 21) received standard gauze dressing; high-risk incisions were randomized 1:1 to negative-pressure therapy (Prevena, P; n ¼ 59) or standard gauze (n ¼ 60) dressing. Wound complication rate, length of stay (LOS), reoperation (ROR), readmission, and variable hospital costs were determined over 30 days. Statistical analysis was performed using the c 2 test. Results: There were no significant demographic differences (age, gender, risk factors for wound complication) between the two high-risk groups. In low-risk controls, the major wound complication rate was 4.8% (1 infection in 21 incisions, average Szilagyi class 2), resulting in a 3.8-day LOS, 4.8% ROR, 4.8% readmission rate, and $17,599 in average cost. For high-risk controls, there was a significant increase in major wound complications (21.7% including 15 infections in 60 incisions, average Szilagyi class 2.4), LOS (10.6 days), ROR (18.3%), readmission (16.7%), and costs ($36,537). Finally, negative-pressure therapy significantly reduced major wound complications (8.5%, including 6 infections in 59 incisions, average Szilagyi class 2.33; P < .001), ROR (8.5%; P < .05), readmission (6.8%; P < .04), and cost ($30,492; P ¼ .11) in the high-risk group but not LOS (10.6 days). Use of the device, costing $500, was associated with a reduction in mean total inpatient cost per patient of $6045 in this study.
Conclusions: This study suggests negative-pressure therapy significantly reduces the major complication rate, ROR, readmission, and hospital costs for patients at high-risk for groin wound complications. Global health care costs may be reduced further considering savings in reduced outpatient treatment of infection and readmission penalties. We recommend negative-pressure therapy for all groin incisions at high-risk for complications.
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Analysis of Dorsalis Pedis Bypass in the
Methods: We reviewed all patients at our institution undergoing either DPB between 2000 and 2014 or tibial PTA/S between 2004 and 2014. For direct comparison, we restricted analyses to procedures performed after 2003, excluded patients who had undergone any prior ipsilateral bypass, and included only PTA/S limbs that were suitable bypass candidates, had TASC C or D disease, and had a potential distal anterior tibial or dorsalis pedis bypass target on angiography. Outcomes included perioperative complications, restenosis (>3.5Â step-up by duplex), reintervention, patency, limb salvage, and survival. Predictors were identified using Kaplan-Meier survival estimates and Cox proportional hazard models. 
